Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells

Acta Biochim Biophys Sin (Shanghai). 2019 Jul 10;51(7):707-714. doi: 10.1093/abbs/gmz058.

Abstract

Alteration in cellular energy metabolism plays a critical role in the development and progression of cancer. Leptin is a hormone secreted by adipose tissue. Recent reports have shown that leptin can induce cancer cell proliferation and regulate cell energy metabolism, but the regulatory mechanism is still unclear. Here, we showed that leptin could promote cell proliferation and maintain high adenosine triphosphate levels in HCT116 and MCF-7 cells. The expression levels of carnitine palmitoyl transferase 1A (CPT1A), pyruvate dehydrogenase, succinate dehydrogenase subunit A and mitochondrial respiratory chain-associated proteins NADH dehydrogenase 1 (ND1), NADH:ubiquinone oxidoreductase subunit B8, and mitochondrial transcription factor A (TFAM) were distinctly increased in leptin-treated HCT116 and MCF-7 cells, while fatty acid synthase and lactate dehydrogenase expression were downregulated. Simultaneously, we found that c-Myc and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC-1) protein expression levels were significantly increased. These results indicated that leptin boosted fatty acid β-oxidation and the tricarboxylic acid cycle, enhanced oxidative phosphorylation (OXPHOS) activity, and inhibited fatty acid synthesis and glycolysis in tumor cells. Gene transfection experiments revealed that leptin could induce the expression of c-Myc. Moreover, the expressions of PGC-1, CPT1A, and TFAM proteins were downregulated in HCT116 cells with low expression of c-Myc, and the expression levels of these proteins were increased in HCT116 cells overexpressing c-Myc. These findings suggest that leptin plays an important role in the regulation of energy metabolism in tumor cells. It may regulate fatty acid oxidation and OXPHOS of tumor cells by regulating the c-Myc/PGC-1 pathway. Targeting metabolic pathways for cancer treatment has been investigated as potential preventive or therapeutic methods. This study has important implications for the clinical therapy of tumor cell metabolism through hormone regulation.

Keywords: OXPHOS; c-Myc/PGC-1 pathway; cancer cells; fatty acid oxidation; leptin.

MeSH terms

  • Carnitine O-Palmitoyltransferase / genetics
  • Carnitine O-Palmitoyltransferase / metabolism
  • Cell Line, Tumor
  • Fatty Acid Synthase, Type I / genetics
  • Fatty Acid Synthase, Type I / metabolism
  • Fatty Acids / metabolism*
  • Gene Expression Regulation, Neoplastic / drug effects
  • HCT116 Cells
  • HEK293 Cells
  • Humans
  • Leptin / genetics
  • Leptin / metabolism
  • Leptin / pharmacology*
  • MCF-7 Cells
  • Metabolic Networks and Pathways / drug effects
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Oxidation-Reduction / drug effects
  • Oxidative Phosphorylation / drug effects*
  • Proto-Oncogene Proteins c-myc / metabolism*
  • Transcription Factors / metabolism*

Substances

  • Fatty Acids
  • Leptin
  • MYC protein, human
  • Proto-Oncogene Proteins c-myc
  • Transcription Factors
  • peroxisome-proliferator-activated receptor-gamma coactivator-1
  • CPT1A protein, human
  • Carnitine O-Palmitoyltransferase
  • FASN protein, human
  • Fatty Acid Synthase, Type I